← Leaderboards
Surachai Supattapone
University Of California San Francisco
$18,121,125
Attributed
$19,791,625
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,791,625 · 13
By mechanism
R01$13,846,562 · 5
R37$2,726,834 · 1
R21$1,681,000 · 3
R56$1,088,059 · 2
K08$370,170 · 1
R03$79,000 · 1
Top collaborators
- Kurt William Zilm6 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Stanley B Prusiner$54,781,835
- Fred E Cohen$5,735,573
- Stephen J. De Armond$4,738,993
- He Liu$566,494
- Kenneth D Miller$8,370,138
Others in their field
Top investigators on “Prions”
- Stanley B Prusiner · University Of California San Francisco$50,216,013
- Claudio Soto · University Of Texas Medical Br Galveston$31,398,981
- Glenn C Telling · Colorado State University$23,470,323
- David A Harris · Washington University$22,508,580
- Stephen M Strittmatter · Yale University$20,347,521
- Witold K Surewicz · Case Western Reserve University$19,852,886
Research focus
PrionsPrion DiseasesMolecular ConformationCreutzfeldt-Jakob SyndromeConformerInfectious AgentMolecularScrapiePrpsc ProteinsIn VitroNeurodegenerative DisordersBrainAnimalsCofactorLaboratoriesBovine Spongiform EncephalopathyInfectionIn VivoBiochemicalPatternChronic Wasting DiseaseAlzheimer&AposParkinson DiseaseS Disease
Grant awards (50)
Mapping Molecular Pathways that Control Prion Metabolism$678,442
R37 · FY2025 · NS · contact PI
Novel Therapeutic Strategies Targeting Malleability of Wild-Type and Mutant Prions$425,221
R01 · FY2025 · NS · contact PI
Mapping Molecular Pathways that Control Prion Metabolism$683,308
R37 · FY2024 · NS · contact PI
Structural Mechanism of Mammalian Prion Infectivity$522,985
R01 · FY2024 · NS · contact PI
Mapping Molecular Pathways that Control Prion Metabolism$678,442
R37 · FY2023 · NS · contact PI
Structural Mechanism of Mammalian Prion Infectivity$539,159
R01 · FY2023 · NS · contact PI
Novel Therapeutic Strategies Targeting Malleability of Wild-Type and Mutant Prions$526,091
R01 · FY2023 · NS · contact PI
Mapping molecular pathways that control prion metabolism$686,642
R37 · FY2022 · NS · contact PI
Structural Mechanism of Mammalian Prion Infectivity$539,159
R01 · FY2022 · NS · contact PI
Novel therapeutic strategies targeting malleability of wild-type and mutant prions$481,937
R01 · FY2022 · NS · contact PI
Structural Mechanism of Mammalian Prion Infectivity$596,911
R01 · FY2021 · NS · contact PI
Dissecting the Mechanism of Prion Formation with a Permissive Host$555,038
R01 · FY2021 · NS · contact PI
Novel therapeutic strategies targeting malleability of wild-type and mutant prions$530,216
R01 · FY2021 · NS · contact PI
Structural Mechanism of Mammalian Prion Infectivity$575,786
R01 · FY2020 · NS · contact PI
Dissecting the Mechanism of Prion Formation with a Permissive Host$553,817
R01 · FY2020 · NS · contact PI
Novel therapeutic strategies targeting malleability of wild-type and mutant prions$472,466
R01 · FY2020 · NS · contact PI
Dissecting the Mechanism of Prion Formation with a Permissive Host$553,817
R01 · FY2019 · NS · contact PI
Dissecting the Mechanism of Prion Formation with a Permissive Host$553,817
R01 · FY2018 · NS · contact PI
Combination Chemotherapy for Treatment of Prion Disease$202,500
R21 · FY2018 · NS · contact PI
Structural Mechanism of Mammalian Prion Infectivity$567,000
R56 · FY2017 · NS · contact PI
Dissecting the Mechanism of Prion Formation with a Permissive Host$521,059
R56 · FY2017 · NS · contact PI
Origin and Mechanism of Promiscuous Prion Strains$422,549
R01 · FY2017 · NS · contact PI
Combination Chemotherapy for Treatment of Prion Disease$243,000
R21 · FY2017 · NS · contact PI
Long-Term Safety, Efficacy, and Mechanism of PERK Inhibition Therapy for Prion Disease$202,500
R21 · FY2017 · NS · contact PI
Origin and Mechanism of Promiscuous Prion Strains$422,549
R01 · FY2016 · NS · contact PI
Long-Term Safety, Efficacy, and Mechanism of PERK Inhibition Therapy for Prion Disease$243,000
R21 · FY2016 · NS · contact PI
Origin and Mechanism of Promiscuous Prion Strains$32,997
R01 · FY2016 · NS · contact PI
Origin and Mechanism of Promiscuous Prion Strains$422,549
R01 · FY2015 · NS · contact PI
Origin and Mechanism of Promiscuous Prion Strains$418,326
R01 · FY2014 · NS · contact PI
Origin and Mechanism of Promiscuous Prion Strains$422,115
R01 · FY2013 · NS · contact PI
Mechanism of Prion Neurotropism$308,508
R01 · FY2012 · NS · contact PI
Mechanism of Prion Neurotropism$308,508
R01 · FY2011 · NS · contact PI
Biochemistry of Infectious Prions$274,229
R01 · FY2011 · NS · contact PI
Mechanism of Prion Neurotropism$311,655
R01 · FY2010 · NS · contact PI
Biochemistry of Infectious Prions$277,027
R01 · FY2010 · NS · contact PI
Mechanism of Prion Neurotropism$314,803
R01 · FY2009 · NS · contact PI
Biochemistry of Infectious Prions$279,825
R01 · FY2009 · NS · contact PI
Mechanism of Prion Neurotropism$314,803
R01 · FY2008 · NS · contact PI
Biochemistry of Infectious Prions$279,825
R01 · FY2008 · NS · contact PI
Mechanism of Prion Propagation$315,547
R01 · FY2007 · NS · contact PI
Biochemistry of Infectious Prions$279,825
R01 · FY2007 · NS · contact PI
Mechanism of Prion Propagation$324,971
R01 · FY2006 · NS · contact PI
Species Susceptibility Assay for Chronic Wasting Disease$395,000
R21 · FY2005 · AI
Mechanism of Prion Propagation$335,140
R01 · FY2005 · NS
Species Susceptibility Assay for Chronic Wasting Disease$395,000
R21 · FY2004 · AI
Mechanism of Prion Propagation$354,391
R01 · FY2004 · NS
Drosophila Models of Prion Disease$79,000
R03 · FY2003 · AG
Dissecting Prion Disease Mechanisms with Transgenic Mice$132,300
K08 · FY2002 · NS
Dissecting Prion Disease Mechanisms with Transgenic Mice$132,300
K08 · FY2001 · NS
DISSECTING PRION DISEASE MECHANISMS WITH TRANSGENIC MICE$105,570
K08 · FY2000 · NS